Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.

The zinc finger protein LMO4 is overexpressed in a high proportion of breast carcinomas. Here, we report that overexpression of a mouse mammary tumor virus (MMTV)-Lmo4 transgene in the mouse mammary gland elicits hyperplasia and mammary intraepithelial neoplasia or adenosquamous carcinoma in two transgenic strains with a tumor latency of 13-18 months. To investigate cellular processes controlled by LMO4 and those that may be deregulated during oncogenesis, we used RNA interference. Down-regulation of LMO4 expression reduced proliferation of human breast cancer cells and increased differentiation of mouse mammary epithelial cells. Furthermore, small-interfering-RNA-transfected breast cancer cells (MDA-MB-231) had a reduced capacity to migrate and invade an extracellular matrix. Conversely, overexpression of LMO4 in noninvasive, immortalized human MCF10A cells promoted cell motility and invasion. Significantly, in a cohort of 159 primary breast cancers, high nuclear levels of LMO4 were an independent predictor of death from breast cancer. Together, these findings suggest that deregulation of LMO4 in breast epithelium contributes directly to breast neoplasia by altering the rate of cellular proliferation and promoting cell invasion.

[1]  J. Visvader,et al.  The LIM Domain Protein Lmo4 Is Highly Expressed in Proliferating Mouse Epithelial Tissues , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  T. Rabbitts,et al.  Null Mutation of the Lmo4 Gene or a Combined Null Mutation of the Lmo1/Lmo3 Genes Causes Perinatal Lethality, and Lmo4 Controls Neural Tube Development in Mice , 2004, Molecular and Cellular Biology.

[3]  S. Orkin,et al.  Defective Neural Tube Closure and Anteroposterior Patterning in Mice Lacking the LIM Protein LMO4 or Its Interacting Partner Deaf-1 , 2004, Molecular and Cellular Biology.

[4]  B. Andersen,et al.  Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice , 2004, Oncogene.

[5]  J. Visvader,et al.  LIM‐domain‐binding protein 1: a multifunctional cofactor that interacts with diverse proteins , 2003, EMBO reports.

[6]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[7]  G. Leuba,et al.  Transcription regulator LMO4 interferes with neuritogenesis in human SH-SY5Y neuroblastoma cells. , 2003, Brain research. Molecular brain research.

[8]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[9]  O. Bernard,et al.  A role for LIM kinase in cancer invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Imai,et al.  The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity , 2003, British Journal of Cancer.

[11]  F. Kittrell,et al.  Functional analysis of cyclin D2 and p27Kip1 in cyclin D2 transgenic mouse mammary gland during development , 2002, Oncogene.

[12]  Xin Yu,et al.  The LIM Domain Protein LMO4 Interacts with the Cofactor CtIP and the Tumor Suppressor BRCA1 and Inhibits BRCA1 Activity* , 2002, The Journal of Biological Chemistry.

[13]  J. Visvader,et al.  The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Cardiff,et al.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.

[15]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Sparano,et al.  Molecular cloning of LMO41, a new human LIM domain gene. , 1999, Biochimica et biophysica acta.

[17]  T. Rabbitts,et al.  LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. , 1998, Genes & development.

[18]  T. Rabbitts,et al.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Bortner,et al.  Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E , 1997, Molecular and cellular biology.

[20]  J. Rehg,et al.  Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice. , 1995, Blood.

[21]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[22]  T. Langford,et al.  T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. , 1994, Oncogene.

[23]  T. Rabbitts,et al.  T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. , 1992, Oncogene.

[24]  G. Sclar,et al.  Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma , 1992, Molecular and cellular biology.

[25]  D. Taverna,et al.  Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[26]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[27]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[28]  P. Leder,et al.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development , 1986, Cell.

[29]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.